What is the management of stent migration after Endoscopic Ultrasonography (EUS)-choledochoduodenostomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Management of stent migration after EUS-choledochoduodenostomy should prioritize prompt intervention with endoscopic retrieval for proximally migrated stents and conservative management with monitoring for distally migrated stents, unless complications arise. The approach to managing stent migration involves several key steps, including confirmation of migration through imaging such as abdominal X-ray, CT scan, or repeat EUS 1.

Assessment and Initial Management

For proximal migration into the bile duct, retrieval can be attempted using endoscopic methods with rat-tooth forceps, snares, or balloon catheters during ERCP or repeat EUS. This approach is technically demanding and should be performed by skilled endoscopists, as highlighted in the context of EUS-BD placement having improved outcomes with experience 1.

Conservative Management

For distally migrated stents that have entered the intestinal tract, conservative management with monitoring is appropriate if the patient is asymptomatic, as most stents will pass naturally within 1-2 weeks. However, close monitoring is crucial to promptly identify any signs of complications.

Prevention of Future Migration

To prevent future migration, considering using stents with anti-migration features such as double-pigtail designs, lumen-apposing metal stents (LAMS), or partially covered self-expandable metal stents with wider flanges is recommended. Proper stent placement technique is also crucial, ensuring at least 1-2 cm of the stent remains within the bile duct and that the distal end is adequately positioned in the duodenum.

Follow-Up

Regular follow-up imaging at 1-3 month intervals is recommended to monitor stent position until removal or exchange is planned, typically at 3-6 months post-procedure. This proactive approach helps in early detection of any potential issues, including stent migration, and allows for timely intervention to prevent serious complications.

From the Research

Management of Stent Migration after EUS-Choledochoduodenostomy

To manage stent migration after EUS-choledochoduodenostomy, several strategies can be employed:

  • Re-intervention: In cases of stent migration, re-intervention may be necessary to replace or reposition the stent 2.
  • Stent design: The use of fully covered or partially covered self-expandable metal stents (SEMS) may help reduce the risk of stent migration 3, 4.
  • Technique: Following the recommended procedure technique and using a cautery-enhanced delivery system may also help minimize the risk of stent migration 5, 6.
  • Patient selection: Careful patient selection and evaluation of the common bile duct diameter may help identify patients at higher risk of stent migration 5.

Risk Factors for Stent Migration

Several risk factors for stent migration have been identified, including:

  • Small diameter of the common bile duct 5
  • Not following the recommended procedure technique 5
  • Type of stent used: Fully covered SEMS may have a higher risk of migration compared to partially covered SEMS 4, 2

Outcomes of EUS-Choledochoduodenostomy

The outcomes of EUS-choledochoduodenostomy using different types of stents have been evaluated in several studies:

  • Technical success rates: 88.5% to 98.2% 5, 2
  • Clinical success rates: 91.6% to 100% 5, 3
  • Stent patency rates: 83% to 396 days 3, 4
  • Adverse event rates: 3.8% to 36.8% 5, 6

Related Questions

What is the management of stent migration in Endoscopic Ultrasonography (EUS) guided choledochoduodenostomy?
What are the indications for Endoscopic Ultrasonography (EUS) guided choledochoduodenostomy?
What is the complication rate after Endoscopic Ultrasonography (EUS) guided choledochoduodenostomy?
What is the management of stent migration after choledochoduodenostomy (surgical creation of a connection between the common bile duct and the duodenum)?
What are the guidelines for Endoscopic Ultrasonography (EUS) guided choledochoduodenostomy?
What is the diagnosis for a 31-year-old individual with a history of health anxiety, experiencing persistent and intense emotional distress, characterized by feelings of torment, weepiness, and dark emotions, despite normal laboratory results, including vitamin D, iron, B12, magnesium, and calcium levels, and a methylation report showing impaired folate and BH4 cycles, after a course of Sertraline (selective serotonin reuptake inhibitor) and supplementation with 5-Hydroxytryptophan (5-HTP)?
What is the likely diagnosis for a 31-year-old individual with a history of health anxiety, who experienced a severe emotional distress episode after a therapy session for agoraphobia, and has since suffered from persistent and intense emotional pain, despite normal laboratory results, including vitamin D, iron, and B12 levels, and a methylation report showing impaired folate and BH4 cycles, with no evidence of anhedonia or numbness?
What is the best neuroimaging modality for evaluating gait instability?
What is the cause of right inguinal lymphadenopathy (lymph node enlargement) in a 5-day-old child?
Should illicit drug use screening be performed in Medicare patients prior to prescribing stimulants, such as those containing methylphenidate (Ritalin)?
What is the estimated weight loss with Tirzepatide (tirzepatide) in the first month?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.